Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help tackle medication shortages in Gloucester constituency.

The Department has a responsibility to work with medicine license holders in the United Kingdom to help ensure continuity of supply. We monitor and manage medicine supply issues at a national level so that stocks remain available to meet regional and local demand and therefore measures are not specific to Gloucester.

We have inherited ongoing global supply problems that continue to impact medicine availability under the new government. We know how frustrating and distressing this can be for patients, and we are working closely with industry, the National Health Service, manufacturers and other partners in the supply chain to resolve issues as quickly as possible to make sure patients can access the medicines they need.

Medicine supply chains are complex, global and highly regulated and there are several reasons why supply can be disrupted, many of which are not specific to the UK and outside of Government control, including manufacturing difficulties, access to raw materials, sudden demand spikes or distribution issues and regulatory issues. There are approximately 14,000 licensed medicines and the overwhelming majority are in good supply.

While we cannot always prevent supply issues from occurring, we have a range of well-established processes and tools to manage them when they arise and mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing NHS communications to provide management advice and information on the issue to healthcare professionals including pharmacists, so they can advise and support their patients.

The resilience of UK supply chains is a key priority, and we are committed to helping to build long term supply chain resilience for medicines. We are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. The Department, working closely with NHS England, is taking forward a range of actions to improve our ability to mitigate and manage shortages and strengthen our resilience.